Depression trials in Australia
12 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Where
- Carlton, Elizabeth Vale, Geelong, Melbourne, Northcote, Toowoomba, Westmead
- Age
- 18 years to 75 years
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07412756 · EU 2025-522308-25-00 - Phase 3Taking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Where
- Brisbane, Bruce, Carlton, Elizabeth Vale, Geelong, Melbourne, Toowoomba, Westmead
- Age
- 18 years to 75 years
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07775300 · EU 2025-522310-24-00 - Phase 3Taking peopleA Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Where
- Camperdown, Maroochydore, Melbourne, Notting Hill
- Age
- 18 years to 85 years
- People
- 330 worldwide
- Run by
- Cybin IRL Limited
See details and how to joinNCT06793397 · EU 2024-519270-40-00 - Phase 3Taking peopleLong-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Carlton, Melbourne
- Age
- 18 years and over
- People
- 850 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06966401 · EU 2024-519423-24-00 - Phase 3Taking peopleA Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Carlton, Melbourne, Parkville
- Age
- 18 years and over
- People
- 550 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07196501 · EU 2025-520541-72-00 - Phase 3Enrolling by invitationPhase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
- Where
- Maroochydore, Melbourne, Notting Hill
- Age
- 18 years to 85 years
- People
- 468 worldwide
- Run by
- Cybin IRL Limited
See details and how to joinNCT06605105 · EU 2024-516805-22-00 - Phase 4Taking peoplePositioning of Esketamine Treatment in the Real-world Management of Depression
- Where
- St Leonards
- Age
- 18 years to 65 years
- People
- 162
- Run by
- Royal North Shore Hospital
See details and how to joinNCT06103760 - Phase 4Taking peopleComparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression
- Where
- Camperdown, Melbourne, Parkville, Randwick, Southport, St Leonards, Warners Bay
- Age
- 18 years and over
- People
- 162
- Run by
- The George Institute
See details and how to joinNCT06278779 - No phaseTaking peopleMaintenance rTMS for Depression (Maitr-De)
- Where
- Canberra
- Age
- 18 years to 80 years
- People
- 75 worldwide
- Run by
- University of California, San Diego
See details and how to joinNCT06938841 - Phase 3Taking peopleREVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
- Where
- Carlton
- Age
- 18 years and over
- People
- 1,900 worldwide
- Run by
- Senseye, Inc.
See details and how to joinNCT07280065 - Phase 1/2Not yet taking people in AustraliaKetamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
- Where
- Sydney
- Age
- 18 years to 70 years
- People
- 20
- Run by
- South West Sydney Local Health District
See details and how to joinNCT07247370 - No phaseNot yet taking people in AustraliaAssessment of Whether Telehealth Family Psychoeducation for Major Depressive Disorder is Doable
- Where
- Bakewell, Palmerston
- Age
- 18 years and over
- People
- 26
- Run by
- University of Southern Queensland
See details and how to joinNCT07014241